TORSKAL

🌿 Green nanoparticles for cancer therapy

General Information
Company Name
TORSKAL
Founded Year
2015
Location (Offices)
Reunion +1
Founders / Decision Makers
Number of Employees
4
Industries
-
Funding Stage
-
Social Media

TORSKAL - Company Profile

TORSKAL is an international biotech/medtech company, a pioneer of green nanotechnology. We design disruptive gold nanoparticles for cancer therapy from green chemistry. We are committed to the development of a new generation of non-toxic and eco-friendly nanomaterials for the treatment of surface and deep cancers by green chemistry. We have discovered an innovative, green, and patented way of producing gold nanoparticles, leveraging Indian Ocean endemic plants, that have many applications in health. Main project: the Nanotheranostics Project (NT1), a treatment for skin cancer using near-infrared (IR) radiation-induced plasmonic phototherapy Deep Cancer program (NT2 & NT3), which aims to develop new nanotheranostics for the treatment of deep cancers such as prostate, bladder and pancreatic cancers We also sell our unique gold nanoparticles through our website's e-commerce platform which has a wide range of applications in diagnostics, research, industry, and others. TORSKAL is currently located in Europe (France, La Réunion) & China

Funding Rounds & Investors of TORSKAL (0)

View All

There is no investment information

Latest News of TORSKAL

View All

No recent news or press coverage available for TORSKAL.

Similar Companies to TORSKAL

View All
Sona Nanotech Inc. - Similar company to TORSKAL
Sona Nanotech Inc. Biocompatible Nanoparticle Technology Being Used to Develop Cancer Therapies & Rapid Diagnostics (CSE:SONA | OTC: SNANF)
Ikena Oncology - Similar company to TORSKAL
Ikena Oncology Patient-directed oncology therapies across pathways relevant in tumor and immune cells
Ora Lee Smith Cancer Research Foundation - Similar company to TORSKAL
Ora Lee Smith Cancer Research Foundation We are moving BEYOND HOPE to change the way cancer is treated!
Oncobox - Similar company to TORSKAL
Oncobox Tailor the right cancer drug to each patient